OBJECTIVE: To The study aims to evaluate the levels of circulating sFlt-1 in pre-eclampsia (PE) and eclampsia patients and to assess its prognostic significance in detection of PE complications. STUDY DESIGN: The current study was a prospective cohort study conducted in tertiary University hospital between January and December 2016. Included patients were divided into two groups; (Group I) severe PE group and (Group II) eclampsia group. Age, parity and gestational age matched women had approached to participate in the study as a control group (Group III). Serum NGAL levels were measured at inclusion with all basic investigations. Patients were followed up until delivery to record any complications. Correlation analysis was performed between the serum NGAL levels and clinical, laboratory investigations. Receiver operating characteristic analysis was constructed for the evaluation of the area under curve (AUC) as well as the sensitivity and specificity regarding the cutoff point of NGAL level that predict occurrence of complications. RESULTS: The study included 94 women. Women with complicated severe PE showed higher NGAL levels than in non complicated cases (1149.1 AE252.9 versus 845.8AE270.9, p¼0.04 Similarly, the mean serum level of NGAL in complicated eclampsia was higher than in non-complicated cases (2313.3 AE1215.2 versus 1526.9 AE821.9, p<0.001) (OR¼1.004, 95% CI: 1.002-1.006, p<0.001). NGAL levels were strongly correlated with SBP (r¼0.585) and DBP (r¼0.564) (p<0.001 and p<0.001 respectively). At cutoff point 1099.39 ng/ml of NGAL serum levels, the sensitivity was 70% and specificity was 76.7% with AUC¼0.881, 95% CI: 0.803-0.959. CONCLUSION: Serum NGAL could be used as a prognostic marker to predict the occurrence of complications of in cases of PE and eclampsia. OBJECTIVE: Preeclampsia is associated with excess risk of future cardiovascular disease (CVD). One hypothesized mechanism is that persistent vascular dysfunction after delivery may link preeclampsia with later CVD. Our aim was to compare vascular resistance and arterial stiffness one-year postpartum following preeclampsia and uncomplicated pregnancy. STUDY DESIGN: This is a case-control study of women with preeclampsia and uncomplicated pregnancies who were prospectively recruited and underwent a follow up visit one year postpartum. Women were recruited from labor and delivery with either uncomplicated pregnancies or with preeclampsia. Outcomes were adjudicated by a panel of study physicians. At one-year postpartum, we used EndoPAT peripheral artery tonometry to measure microvascular vasodilatory response to postischemic hyperemia and arterial stiffness [augmentation index (AI) and augmentation index normalized to heart rate, with lower values reflecting more arterial elasticity]. Bioreactance cardiography was performed using the NICOM device to assess hemodynamics adjusted for body surface area, including cardiac index (CI) and total peripheral resistance index (TPRI). Statistical analysis was performed using univariate analysis. RESULTS: Fourteen women with prior preeclampsia were compared to twenty-four controls at a mean time point of 12.8 AE 1.4 months postpartum. Demographic characteristics and blood pressure postpartum were similar between groups. Prior preeclampsia was associated with higher AI compared to uncomplicated pregnancies (median -7.6% vs. -2.1%, p¼0.04) indicating increased arterial stiffness. There was no difference in cardiac index between groups (median 3.6 vs. 3.7 L/min/m 2 , p¼0.9), however TPRI was significantly higher in women with prior preeclampsia (median 1781 vs. 1987 dynes-sec/cm 5 /m 2 , p¼0.04). CONCLUSION: In this prospective cohort followed one year postpartum we show significant differences in vascular function associated with prior preeclampsia with higher vascular resistance and increased arterial stiffness using non-invasive vascular assessments. These measures have been extensively validated in a non-obstetric population and are associated with CVD risk. These findings may provide insight into mechanisms linking preeclampsia to future CVD and the identified post-preeclampsia physiology may be a target for risk-reducing interventions.
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